REGN Icon

$REGN

$REGN

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degenerat...

Stocks

Total Asset Value

$13,817

▲+30.26%from 30d ago

Holders

87

▲+16.00%from 30d ago

Monthly Transfer Volume

$2.37M

▲+889.91%from 30d ago

Regeneron Pharmaceuticals Metrics

Tokenized Public Stocks

10 Total